Cancer Family

Hematopoietic and Lymphoid Cell Neoplasm

HematologicNon-malignant4,231 active trials98 approved drugs1,009 evidence items

NCIt: C27134
DOID: 2531
MeSH: D019337

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (735)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 151–175 of 735 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

E-lesion or stage IV disease? An ongoing unsettled issue in pediatric Hodgkin lymphoma.
Jennifer Seelisch, Christine Mauz-Koerholz, Kara M Kelly et al. · Blood Adv · Sep 8, 2026 · PMID 42361346 · candidate dictionary pubmed
EuroNet-PHL-LP1: complete resection or low-dose chemotherapy for pediatric low-risk nodular lymphocyte-predominant Hodgkin lymphoma.
Ananth Shankar, Judith Landman-Parker, Maurizio Mascarin et al. · Blood Adv · Sep 8, 2026 · PMID 42234940 · candidate dictionary pubmed
Safety and efficacy of allogeneic CD19-directed CAR-T therapy CTX110 in relapsed/refractory B-cell non-Hodgkin lymphoma.
Joseph P McGuirk, Armin Ghobadi, Carlos R Bachier et al. · Blood Adv · Sep 8, 2026 · PMID 42085626 · candidate dictionary pubmed
Adapting a mental health program for people with multiple myeloma and smouldering myeloma: a consumer-informed feasibility study.
Natalie Tuckey, Matthew Iasiello, Melissa Cantley et al. · Support Care Cancer · Sep 8, 2026 · PMID 42706438 · candidate dictionary pubmed
Heestermans R, Olsen C, Ameli S, et al. Blood-derived cell-free DNA is a superior biomarker for noninvasive DNA methylation profiling in multiple myeloma. Blood Adv. 2025;9(16):4306-4310.
· Blood Adv · Sep 8, 2026 · PMID 42664001 · candidate dictionary pubmed
TNFRSF17 genomic profiling guides retreatment with alternative BCMA-directed immunotherapies in multiple myeloma.
Benjamin Podvin, Holly Lee, Rémi Tilmont et al. · Blood Adv · Sep 8, 2026 · PMID 42418388 · candidate dictionary pubmed

Clinical course, risk factors, and therapeutic response in multiple myeloma with central nervous system involvement.

Alexander Xiao, Saurabh Zanwar, Yi Lin et al. · Blood Adv · Sep 8, 2026 · PMID 42348786 · candidate dictionary pubmed

Cellular Rhythm for Label-Free Tracking of Apoptotic Progression in Leukemia Cells.

Yunpeng Yang, Feng Gao, Xiaopeng Yang et al. · Anal Chem · Sep 8, 2026 · PMID 42669290 · candidate dictionary pubmed

Classic Hodgkin Lymphoma: A Review.

Kishan K Patel, Alison J Moskowitz · JAMA · Sep 8, 2026 · PMID 42545803 · candidate dictionary pubmed

CD84 expression stratifies venetoclax response and reveals a targetable vulnerability in resistant acute myeloid leukemia.

Xuemei Wang, Xiangjie Lin, Tianyi Chen et al. · Exp Hematol Oncol · Sep 7, 2026 · PMID 42706583 · candidate dictionary pubmed

Management of Clostridioides difficile infections in patients with hematological malignancies - a survey by European Conference on Infections in Leukemia (ECIL) and Infectious Diseases Working Party (IDWP) of The European Society for Blood and Marrow Transplantation (EBMT).

Agnieszka Piekarska, Chiara Oltolini, Benjamin W Teh et al. · Int J Infect Dis · Sep 7, 2026 · PMID 42705408 · candidate dictionary pubmed

Clinical characteristics, prognosis, and achievement of transplant in adolescents and adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in Argentina.

María Manuela Clavijo, Juan Ignacio Ruiz, Luciana Ferrari et al. · Hematol Transfus Cell Ther · Sep 7, 2026 · PMID 42705001 · candidate dictionary pubmed

Pharmacogenomic diversity in Amazonian Indigenous populations: implications for Berlin-Frankfurt-Münster acute lymphoblastic leukemia therapy.

Luciana Pereira Colares Leitão, Natasha Monte, Juliana Carla Rodrigues Marcellino et al. · Clin Transl Oncol · Sep 7, 2026 · PMID 42704601 · candidate dictionary pubmed

Therapeutic drug monitoring in leukemia: global research trends and implications for clinical pharmacy practice-a bibliometric analysis.

Jianchun Li, Lichaoyue Sun, Shuo Liang et al. · Int J Clin Pharm · Sep 7, 2026 · PMID 42704521 · candidate dictionary pubmed

Constructing an External Control Arm Using the French REALYSA Cohort to Replicate Outcomes of a Randomized Trial Arm in Advanced Hodgkin Lymphoma.

Olivia Febvey-Combes, Cédric Rossi, Behrouz Kassai et al. · Clin Pharmacol Ther · Sep 7, 2026 · PMID 42704204 · candidate dictionary pubmed

Comment on "Exceptional long-term responses from OCEAN and HORIZON trials: melflufen-dexamethasone as an expansion of treatment options for relapsed/refractory multiple myeloma in the era of new immunotherapies?".

Manish R Bhise, Akshay Akotkar, Shweta Bhandari et al. · J Cancer Res Clin Oncol · Sep 7, 2026 · PMID 42706433 · candidate dictionary pubmed

Circulating tumor cells identify a disseminated genomic high-risk phenotype within IMS-IMWG 2025 staging in newly diagnosed multiple myeloma.

Yating Li, Lihui Shi, Wenqiang Yan et al. · Leukemia · Sep 7, 2026 · PMID 42706314 · candidate dictionary pubmed

Myeloma engraftment suppresses osteocytic ossification signatures rescued by loading in mice and reveals predictors of patient outcome.

Fani Ziouti, Muhammad Azeem, Maximilian Rummler et al. · Bone · Sep 7, 2026 · PMID 42705405 · candidate dictionary pubmed

Activating a novel cell death pathway to target PI-resistant multiple myeloma and enhance immunogenic cell death.

Xinyun Zhang, Zhiming Wang, Yilei Shi et al. · Apoptosis · Sep 7, 2026 · PMID 42704369 · candidate dictionary pubmed

Cutaneous Langerhans Cell Sarcoma Harboring BRAF V600E Mutation Followed by Chronic Myelomonocytic Leukemia and EBV-Positive Diffuse Large B-Cell Lymphoma.

Seung Hyo Cho, Su Min Lee, Jee-Bum Lee et al. · J Cutan Pathol · Sep 6, 2026 · PMID 42702547 · candidate dictionary pubmed

Treatment-Free Remission in Chronic Myeloid Leukemia: Toward Precision and Personalized Approaches to Functional Cure.

Hiroshi Ureshino, Shinya Kimura · Cancer Sci · Sep 6, 2026 · PMID 42702363 · candidate dictionary pubmed

Acute leukemia therapy at a crossroads: from conventional chemotherapy to the era of precision medicine.

Naoko Hosono, Naoko Ida, Takahiro Yamauchi · Biochem Pharmacol · Sep 6, 2026 · PMID 42702241 · candidate dictionary pubmed

Targeted RNA sequencing supports risk stratification and treatment decision-making in adolescents and young adult and adult patients with acute lymphoblastic leukemia: a UK single-center experience.

Athanasia Papadaki, Robert Baker, Elisabeth Nacheva et al. · Leuk Lymphoma · Sep 6, 2026 · PMID 42702062 · candidate dictionary pubmed

Response to Borrás-Blasco et al. regarding "Real-world venetoclax dosing patterns and treatment persistence in patients with acute myeloid leukemia: a community pharmacy database study in Japan".

Yuki Goshima, Tomoya Saika, Yuki Kado et al. · Leuk Lymphoma · Sep 6, 2026 · PMID 42702055 · candidate dictionary pubmed

Revisiting invasive fungal infections in acute lymphoblastic leukemia: a systematic review and meta-analysis.

Christian M Farag, Ann Mercurio, Rejowana Rouf et al. · Leuk Lymphoma · Sep 6, 2026 · PMID 42702054 · candidate dictionary pubmed